Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 3/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.39 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | BAX | Q07812 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2064518 | 0.78 | CA4 (0.46) | LTA4HTSHRCA4CA9CA1 | |
| SCHEMBL367452 | 0.78 | CA4 (0.46) | LTA4HTSHRCA4CA9CA1 | |
| SCHEMBL2001538 | 0.72 | CA4 (0.41) | LTA4HTSHRCA4CA9CA1 | |
| SCHEMBL15477270 | 0.72 | CA4 (0.52) | LTA4HTSHRCA4CA9CA1 | |
| SCHEMBL66653 | 0.65 | — | — | |
| SCHEMBL1057667 | 0.65 | — | — | |
| SCHEMBL3955287 | 0.65 | — | — | |
| SCHEMBL14905 | 0.63 | LTA4H (0.60) | LTA4HTSHRCA4CA9CA1 | |
| Diphenylether SCHEMBL9061108 | 0.63 | LTA4H (1.00) | LTA4HTSHRCA4CA9CA1 | |
| Diphenylether SCHEMBL2461810 | 0.63 | LTA4H (1.00) | LTA4HTSHRCA4CA9CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119661831-A | Compositions and methods for targeted RNA delivery | 维乎医疗有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119317594-A | Method for preparing hydrazine hydrate by utilizing absorption tower | 阿科玛法国 | 2025-01-14 | — | — | CN | disclosed |
| CN-119317595-A | Process for the preparation of azines using cascade reactors | 阿科玛法国 | 2025-01-14 | — | — | CN | disclosed |
| CN-119137271-A | Compositions and methods for capping RNA | 维乎医疗有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-115484932-B | Compositions and methods for targeted RNA delivery | 维乎医疗有限公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-118076360-A | Compositions and methods for targeted RNA delivery | 维乎医疗有限公司 | 2024-05-24 | — | — | CN | disclosed |
| EP-3221340-B1 | DIAGNOSTIC METHOD EMPLOYING HUMAN NEUTROPHIL LIPOCALIN (HNL) | P & M VENGE AB (SE) | 2024-05-22 | — | — | EP | disclosed |
| CN-110702921-B | Methods and compositions for diagnosing and prognosing kidney injury and renal failure | 阿斯图特医药公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-110291197-B | Detection method | 基因复制股份有限公司 | 2024-01-12 | — | — | CN | disclosed |
| EP-3858948-B1 | QUANTUM DOT | TCL TECH GROUP CORP (CN) | 2023-11-22 | — | — | EP | disclosed |
| US-20020115566-A1 | Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2002-08-22 | — | — | US | disclosed |
| US-20020026047-A1 | Calixpyrroles, calixpyridinopyrroles, and calixpyridines | BOARD OF REGENTS, THE | 2002-02-28 | — | — | US | disclosed |
| US-6262257-B1 | SELECTIVE ION- AND NEUTRAL MOLECULE-BINDING AGENTS FORMING SUPRAMOLECULAR ENSEMBLES, AND ION- AND NEUTRAL MOLECULE-SEPARATION AGENTS | BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM | 2001-07-17 | — | — | US | disclosed |
| US-6126743-A | REACTING THREE DIFFERENT METAL OXIDES OR COMPOUNDS OF SPECIFIC DIAMETERS, FIRING OR HEATING THE MIXTURE AT A TEMPERATURE 400-1200 DEGREE C AT WHICH CRYSTAL PHASE CAN BE FORMED | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-10-03 | — | — | US | disclosed |
| EP-0891364-A1 | CALIXPYRROLES, CALIXPYRIDINOPYRROLES AND CALIXPYRIDINES | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1999-01-20 | — | — | EP | disclosed |
| WO-1997037995-A1 | CALIXPYRROLES, CALIXPYRIDINOPYRROLES AND CALIXPYRIDINES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1997-10-16 | — | — | WO | disclosed |
| US-5422038-A | Ferroelectric liquid crystal material with sufficient spontaneous polarization, high speed response capability, wide temperature range | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-06-06 | — | — | US | disclosed |
| EP-0416946-B1 | Optically active naphthalene derivative, process for preparation thereof, liquid crystal composition containing the same as effective component, and liquid crystal element using the same | SUMITOMO CHEMICAL CO (JP) | 1994-11-09 | — | — | EP | disclosed |
| EP-0416946-A2 | Optically active naphthalene derivative, process for preparation thereof, liquid crystal composition containing the same as effective component, and liquid crystal element using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-03-13 | — | — | EP | disclosed |
| US-4788346-A | NITRATION WITH PHENYL INORGANIC ACID ESTER IN HYDROFLUORIC ACID AND THEN HYDROLYSIS | RHONE-POULENC CHIMIE (FR) | 1988-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115566-A1 | Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof | CALD1, CALU, CLASP1 | LTA4H 4629/4885TSHR 370/4885CA4 2083/4885 |
| US-20020026047-A1 | Calixpyrroles, calixpyridinopyrroles, and calixpyridines | CALD1, DAP3, CALR | LTA4H 4295/4885TSHR 1925/4885CA4 194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.